Endophthalmitis is a devastating ocular disorder that leads to visual blindness. Rapid detection and identification of the causative pathogens is crucial for vision-saving diagnosis and treatment.
The surge in genomics and proteomics research for disease diagnosis, drug discovery, and personalized medicine is a primary driver of the DNA microarray market. Applications in Disease Diagnostics: ...
NEWARK, Del, March 19, 2024 (GLOBE NEWSWIRE) -- The DNA microarray market is estimated to be worth US$ 4.1 billion in 2024 and is projected to be valued at US$ 9.9 billion in 2034. Between 2024 and ...
As genomics morphs into proteomics and the quest to understand the biological functions of proteins accelerates, researchers continue to look for the best methods that will speed their understanding; ...
Takara Bio Inc., a biotechnology company in Otsu, Japan, has developed a system which allows for mass production of a wide variety of DNA (deoxyribonucleic acid) fragments needed to make DNA ...
According to a recent report by Market.us, the Global DNA Microarray Market size is expected to be worth around USD 4,593.7 Million by 2033 from USD 1,994.6 Million in 2023, growing at a CAGR of 8.7% ...
The late 1980s were heady days for molecular biologists. PCR was only a few years old. The automated DNA sequencer had just been invented. The Human Genome Project was being debated in Congress.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results